Pharmacogenetics and pharmacogenomics

NICE recommends phased roll out of genetic testing for clopidogrel prescribing

In draft guidance, the National Institute for Health and Care Excellence said that testing could be rolled out to patients at higher risk of stroke recurrence first, while capacity is established.…

DOACs to be analysed as part of genetic biobank scheme

Patients who report adverse effects from direct oral anticoagulants to the Yellow Card scheme may be contacted to provide a blood sample, from which data will then be added to a biobank for researchers to analyse.…

Test your knowledge on mental health

An opportunity to test your knowledge on a range of mental health conditions and interventions.…

NHS England to integrate genomic medicine into pharmacy education and training

In a new framework, NHS England says it aims to develop the pharmacy workforce to incorporate pharmacogenomics into routine care over the next three years.…

Pharmacogenomics and medicines optimisation to be one of eight NHS ‘genomic networks of excellence’

The network will focus on developing the rollout of pharmacogenomics and medicines optimisation in the NHS, including in primary care to address adverse drug reactions.…

Widespread pharmacogenomic testing in psychiatry needs a stronger evidence base

More research into the genomic factors influencing psychiatric medicines response is needed before widespread pharmacogenomic testing can be justified.…

Expanded genetic profiling could guide cancer treatment, study finds

Researchers analysed whole-genome data with data from the NHS, revealing genetic changes in cancers that may affect survival rates and patient outcomes.…

Geraldine McCaffrey: ‘The advances we’re making in Wales are really exciting’

The recently elected chair of the Royal Pharmaceutical Society’s Welsh Pharmacy Board talks to The Pharmaceutical Journal about the Society’s role in assisting the evolving workforce in Wales.…

Pharmacists asked for views on implementing pharmacogenetics in the NHS

Participants in a survey will be presented with a series of hypothetical options related to using pharmacogenetics in the prescribing process, as part of a pilot programme.…

Clopidogrel may be less effective in British South Asian patients, study results suggest

The study authors concluded that non-CYP2C19-dependent antiplatelet agents would likely have a "disproportionate benefit" in the British South Asian population.…